India seeks details of Uzbekistan's investigation into cough syrup deaths case

Published On 2022-12-30 07:45 GMT   |   Update On 2022-12-31 04:32 GMT
Advertisement

New Delhi: India is in touch with the Uzbak authorities and has sought details of their investigation into the death of 18 children after allegedly consuming cough syrup made by an Indian firm, the External Affairs Ministry said on Thursday. MEA spokesperson Arindam Bagchi also said consular assistance is being provided to some linked to the company who are facing legal action there.

Noting that the Uzbek authorities have not formally taken up the matter with New Delhi, he said, "nevertheless, our embassy has contacted the Uzbek side and is seeking further details of their investigation. We understand that legal action has been initiated by the Uzbek authorities against some people, including the local representative of the company there".
"And in that context, we are extending necessary consular assistance to those individuals or individuals," he said.
The comments came even as a probe has already been launched by the Central Drugs Standard Control Organisation in connection with the death of 18 children in Uzbekistan allegedly linked to the cough syrup, while the manufacturing of Marion Biotech's Dok-1 Max has also been suspended.

"There is no problem from our end and no issue in testing. We have been theree for the past ten years. Once the government report will come, we will look into it. For now the manufacturing has stopped," Hasan Harris, legal representative of Marion Biotech told PTI

Union Health Minister Mansukh Mandaviya also said further action would be taken based on the inspection of the pharma company.  

Marion Biotech, does not sell cough syrup, 'Doc-1 Max', in India, and its only export has been to Uzbekistan.  

Read also: Marion Biotech stops production of cough syrup linked to death of 18 kids in Uzbekistan, CDSCO initiates probe 

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News